Reference priceEUR €51.39Original source price: INR 4,671.56. Converted estimates are available by currency selection.
| Brand | Cipla Ltd. |
|---|---|
| Manufacturer | Cipla Ltd. |
| Prescription required | Yes |
Piciclib 75mg Capsule
Palbociclib (75mg)
Description
Piciclib 75mg is a targeted therapy containing the active constituent palbociclib. It belongs to the group of anticancer medications known as cyclin-dependent kinase inhibitors. It is used in treating hormone receptor-positive, human epidermal growth factor 2 negative advanced or metastatic (has spread to other parts of the body) breast cancer. Cancer is a condition in which cells multiply in an uncontrolled and abnormal manner. It is given in combination with certain other anticancer medications.Benefits
In Breast cancer Piciclib 75mg Capsule helps to treat breast cancer and it may be used alone or in combination with other medicines or treatment modalities like chemotherapy. It relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipples or changes in the shape or texture of the breast. Piciclib 75mg Capsule kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Discuss with your doctor if any of the side effects bother you.How to Use
Take this medicine in the dose and duration as advised by your doctor.Specification
Take this medicine in the dose and duration as advised by your doctor.Side Effects
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them Common side effects of Piciclib Decreased blood cells (red cells, white cells, and platelets) Fatigue Hair loss Rash Vomiting Diarrhea Nausea Decreased appetite Infection Decreased white blood cell count Stomatitis (Inflammation of the mouth) Anemia (low number of red blood cells) Weakness FeverCes informations sont fournies à titre indicatif. Demandez conseil à un professionnel de santé avant d'utiliser un médicament.